Analyst Coverage
Stock price graph

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Repros Therapeutics Inc.'s financial performance into perspective.

Recent Releases

Aug 15, 2016
Repros Provides Six Month Interim Results for Enclomiphene Study in Obese Secondary Hypogonadal Men

Aug 9, 2016
Repros Therapeutics Inc.® Reports Second Quarter 2016 Financial Results

View all releases »

2408 Timberloch Place, B-7
The Woodlands, Texas 77380
281-719-3446 fax